New Apple ResearchKit studies target autism, melanoma, epilepsy
A new series of HealthKit and ResearchKit studies, the SDKs developed by Apple for health research on the companys tech devices, are focusing on autism, epilepsy and melanoma. Duke University and Duke Health are partnering with Peking University in a study that uses the iPhone's camera to measure a child's reaction to videos played on the phone. The use of apps enables researchers to reach more people than previously and opens the way for potential automated screening for autism and anxiety. At the Oregon Health & Science University, researchers are using the iPhone camera to document changes in moles. Tens of thousands of participants worldwide will send images which will be used to create detection algorithms for future melanoma screening studies. At Johns Hopkins, researchers are using sensors in the Apple Watch to detect the onset and duration of seizures in people with epilepsy. The EpiWatch app logs the seizures and the user's responses, while also tracking medication adherence and side effects.

Alberta Spreafico, managing director of digital health and innovation at Healthware, shares how the report can guide companies' go-to-market strategies for entering the European market.